Management of Helicobacter pylori infection—the Maastricht IV/Florence consensus report P Malfertheiner, F Megraud, CA O'Morain, J Atherton, ATR Axon, ... Gut 61 (5), 646-664, 2012 | 7559* | 2012 |
Management of Helicobacter pylori infection—the Maastricht V/Florence consensus report P Malfertheiner, F Mégraud, CA O'Morain, JP Gisbert, EJ Kuipers, ... Gut 66 (1), 6-30, 2017 | 4072* | 2017 |
Vedolizumab as induction and maintenance therapy for ulcerative colitis BG Feagan, P Rutgeerts, BE Sands, S Hanauer, JF Colombel, ... New England Journal of Medicine 369 (8), 699-710, 2013 | 2772 | 2013 |
Vedolizumab as induction and maintenance therapy for Crohn's disease WJ Sandborn, BG Feagan, P Rutgeerts, S Hanauer, JF Colombel, ... New England Journal of Medicine 369 (8), 711-721, 2013 | 2442 | 2013 |
Ustekinumab as induction and maintenance therapy for Crohn’s disease BG Feagan, WJ Sandborn, C Gasink, D Jacobstein, Y Lang, JR Friedman, ... New England journal of medicine 375 (20), 1946-1960, 2016 | 1886 | 2016 |
Tofacitinib as induction and maintenance therapy for ulcerative colitis WJ Sandborn, C Su, BE Sands, GR D’Haens, S Vermeire, S Schreiber, ... New England Journal of Medicine 376 (18), 1723-1736, 2017 | 1816 | 2017 |
ECCO guidelines on therapeutics in Crohn's disease: medical treatment J Torres, S Bonovas, G Doherty, T Kucharzik, JP Gisbert, T Raine, ... Journal of Crohn's and Colitis 14 (1), 4-22, 2020 | 1310 | 2020 |
Ustekinumab induction and maintenance therapy in refractory Crohn's disease WJ Sandborn, C Gasink, LL Gao, MA Blank, J Johanns, C Guzzo, ... New England Journal of Medicine 367 (16), 1519-1528, 2012 | 1284 | 2012 |
Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption F Megraud, S Coenen, A Versporten, M Kist, M Lopez-Brea, AM Hirschl, ... Gut 62 (1), 34-42, 2013 | 1171 | 2013 |
Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening E Quintero, A Castells, L Bujanda, J Cubiella, D Salas, Á Lanas, ... New England Journal of Medicine 366 (8), 697-706, 2012 | 1160 | 2012 |
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial J Panés, D García-Olmo, G Van Assche, JF Colombel, W Reinisch, ... The Lancet 388 (10051), 1281-1290, 2016 | 1074 | 2016 |
The Toronto consensus for the treatment of Helicobacter pylori infection in adults CA Fallone, N Chiba, SV van Zanten, L Fischbach, JP Gisbert, RH Hunt, ... Gastroenterology 151 (1), 51-69. e14, 2016 | 1051 | 2016 |
Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report P Malfertheiner, F Megraud, T Rokkas, JP Gisbert, JM Liou, C Schulz, ... Gut 71 (9), 1724-1762, 2022 | 970* | 2022 |
Loss of response and requirement of infliximab dose intensification in Crohn's disease: a review JP Gisbert, J Panés Official journal of the American College of Gastroenterology| ACG 104 (3 …, 2009 | 812 | 2009 |
Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn … J Panes, R Bouzas, M Chaparro, V García‐Sánchez, JP Gisbert, ... Alimentary pharmacology & therapeutics 34 (2), 125-145, 2011 | 790 | 2011 |
European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases AU Dignass, C Gasche, D Bettenworth, G Birgegård, S Danese, ... Journal of Crohn's and Colitis 9 (3), 211-222, 2015 | 748* | 2015 |
Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple … P Malfertheiner, F Bazzoli, JC Delchier, K Celiñski, M Giguère, M Rivière, ... The Lancet 377 (9769), 905-913, 2011 | 746 | 2011 |
Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice A Lanas, LA García-Rodríguez, M Polo-Tomás, M Ponce, I Alonso-Abreu, ... Official journal of the American College of Gastroenterology| ACG 104 (7 …, 2009 | 711 | 2009 |
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial D Laharie, A Bourreille, J Branche, M Allez, Y Bouhnik, J Filippi, F Zerbib, ... The Lancet 380 (9857), 1909-1915, 2012 | 681 | 2012 |
ECCO guidelines on therapeutics in ulcerative colitis: medical treatment T Raine, S Bonovas, J Burisch, T Kucharzik, M Adamina, V Annese, ... Journal of Crohn's and Colitis 16 (1), 2-17, 2022 | 629 | 2022 |